Rexam Plc-adr: (OTC: REXMY)
$39.79
-0.60 (-1.49%)
Volume 110,165
May 17 03:49 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 39.42 - 40.13 |
| 52wk Low - High | 33.56 - 41.49 |
| Previous Close | 40.39 |
| Avg. Volume | 58,751 |
| Industry | PAPER &REL PRDS |
| Market Cap | 6.28 B |
| Div - Yield | 1.22 - 3.07 |
| Beta | 1.07 |
| PE (Forward) | 12.62 |
| Current Year Est. | 3.15 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
 3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
191 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | 12.62 |
| PEG Ratio | 1.91 |
| Current Year Est. | 3.15 |
| Current Quarter Estimate | NA |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 05-21-2013 |
| EPS Last Year | NA |
| Expected Earnings Growth | 6.62% |
Company Description
Rexam plc manufactures packaging materials, buildings supplies and printed materials. The Company produces corrugated packaging, polypropylene cloth and webbing, paper and plastic bags, beverage containers, lottery tickets, books, business forms, checks, window frames and metal connector plates.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (03/2013) |
Next Qtr (06/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | 3.15 | 3.39 |
| Number of Estimates | 0 | 0 | 4 | 4 |
| Low Estimate | NA | NA | 3.10 | 3.32 |
| High Estimate | NA | NA | 3.20 | NA |
| Year Ago EPS | NA | NA | 3.30 | 3.15 |
| EPS Growth | NA | NA | -4.47% | 7.61% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| REXAM PLC-ADR | REXMY | 39.79 | |
|
| GLATFELTER | GLT | 25.07 | |
|
| RESOLUTE FOREST | RFP | 16.17 | |
|
| BOISE INC | BZ | 7.88 | |
|
| BUCKEYE TECH | BKI | 37.50 | |
|
| DOMTAR CORP | UFS | 72.65 | |
|
| FIBRIA CELULOSE | FBR | 10.55 | |
|
| INTL PAPER | IP | 48.18 | |
|
| KAPSTONE PAPER | KS | 28.38 | |
|
| ROCK-TENN CO | RKT | 100.17 | |
|
Sector:Basic Materials>> Industry:PAPER &REL PRDS
COMPARE TICKER vs. Its Peers
Zacks Commentary
AptarGroup In Line, Falls YoY
Nov 05, 2012
In Line 3Q for Crown Holdings
Oct 18, 2012
West Pharmaceutical Hikes Dividend
Oct 03, 2012
West Pharma Reaches New 52-Week High
Oct 02, 2012
West Pharmaceutical Intros B.safe
Sep 12, 2012
The Zacks Analyst Blog Highlights: Goldman Sachs Group, Carlyle Group, Vale, West Pharmaceutical and Rexam
Sep 11, 2012
West Pharma Ties with Janssen Biotech
Sep 10, 2012
West Sets Up New Facility in India
Aug 24, 2012
Financials
| EPS TTM | NA |
| Sales | 6,668 |
| Net Income | NA |
| Price/Earnings | NA |
| Price/Book | 1.73 |
| Price/Cash Flow | 10.81 |
| Price/Sales | NA |
News
Marley's One Drop Re-launches in Rexam 12oz. SLEEKA? Can - Pr Newswire
May 16, 2013
Lift Bridge Brewing Company launches Farm Girl SaisonA? in Rexam 16oz. Cans - Pr Newswire
May 14, 2013
Fuga Energy Drink Hits the Market in Rexam 12oz. SLEEKA? Can - Pr Newswire
Apr 30, 2013
SanTan Brewing's Mr. Pineapple Wheat Ale Debuts in Rexam 12oz. Cans - Pr Newswire
Mar 19, 2013
Beverage Packaging - Global Business Strategic Report - M2
Feb 20, 2013
Intranasal Drug Delivery - 2012 Global Business Strategic Report Features 71 Companies Including Many Key and Niche Players - M2
Feb 19, 2013
Research and Markets: Intranasal Drug Delivery - 2012 Global Business Strategic Report Features 71 Companies Including Many Key and Niche Players - Businesswire
Feb 19, 2013
Rexam reports share capital structure - M2
Jan 29, 2013
Broker Recommendations
| Current ABR | 2.00 |
| ABR (Last Week) | 2.00 |
| # of recs in ABR | 6 |
| Average Target Price | 48.64 |
| Industry Rank by ABR | 191 out of 265 |
| Rank in Industry | 3 out of 18 |
